Liberty Biopharma Inc (CVE:LTY – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Stock Performance
The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19. The business has a 50 day moving average price of C$2.00 and a 200 day moving average price of C$2.00. The stock has a market cap of C$21.54 million and a P/E ratio of -12.66.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- Election Stocks: How Elections Affect the Stock Market
- MercadoLibre Targets Double-Digit Upside with Argentina Boom
- How to Use the MarketBeat Excel Dividend Calculator
- Domino’s Pizza Stock Delivers: A Hot Buy for Growth Investors
- What is the Australian Securities Exchange (ASX)
- 3 Small-Cap Stocks Ready to Deliver Significant Growth
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
